BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

The diagram shows the blood cell antigens as targets of cancer immunotherapy and the approved products. These are, among others, divided into Car-T cells, conjugated monoclonal antibodies, bispecific monoclonal antibodies and fusion proteins.
Source: BfArM